Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain

Author： Plans-Rubió P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.5, 1998-05, pp. : 623-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy

By Berto P.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 109-121

Adis International

Access to resources Recommend Favorite

Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada

By Morris S.  

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Cholesterol-Lowering Therapies in Spain

By Plans-Rubió Pedro  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 177-188

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease

By Hay Joel W.  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 133-141

Adis International

Access to resources Recommend Favorite

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness

By Ho Wai Khoon   Hankey Graeme J   Eikelboom John W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 493-503

Informa Healthcare

Access to resources Recommend Favorite